10x Genomics Research and Development Expenses 2018-2025 | TXG

10x Genomics research and development expenses from 2018 to 2025. Research and development expenses can be defined as an expense arising from studies and product development processes.
10x Genomics Annual Research and Development Expenses
(Millions of US $)
2024 $265
2023 $270
2022 $266
2021 $212
2020 $123
2019 $83
2018 $48
2017 $32
10x Genomics Quarterly Research and Development Expenses
(Millions of US $)
2025-03-31 $64
2024-12-31 $67
2024-09-30 $66
2024-06-30 $63
2024-03-31 $69
2023-12-31 $65
2023-09-30 $67
2023-06-30 $71
2023-03-31 $67
2022-12-31 $64
2022-09-30 $67
2022-06-30 $71
2022-03-31 $64
2021-12-31 $62
2021-09-30 $55
2021-06-30 $53
2021-03-31 $42
2020-12-31 $40
2020-09-30 $30
2020-06-30 $28
2020-03-31 $26
2019-12-31 $28
2019-09-30 $22
2019-06-30 $18
2019-03-31 $15
2018-12-31
2017-12-31
Sector Industry Market Cap Revenue
Medical MEDICAL INFO SYS $1.496B $0.611B
10x Genomics Inc. is a life science technology company. It develops and sells instruments, consumables and software for analyzing biological systems. 10x Genomics Inc. is based in Pleasanton, California.
Stock Name Country Market Cap PE Ratio
Veeva Systems (VEEV) US $46.130B 58.69
Doximity (DOCS) US $11.290B 52.27
Hims & Hers Health (HIMS) US $11.277B 117.16
Tempus AI (TEM) US $10.557B 0.00
IRhythm Technologies (IRTC) US $4.350B 0.00
Inspire Medical Systems (INSP) US $3.741B 58.45
Hinge Health (HNGE) US $3.664B 0.00
Privia Health (PRVA) US $2.391B 163.42
Schrodinger (SDGR) US $1.574B 0.00
Phreesia (PHR) US $1.516B 0.00
Enovis (ENOV) US $1.502B 8.37
Clover Health Investments (CLOV) US $1.496B 0.00
Azenta (AZTA) US $1.427B 66.30
Omnicell (OMCL) US $1.259B 22.22
Evolent Health (EVH) US $1.119B 95.30
Claritev (CTEV) US $0.702B 0.00
Fulgent Genetics (FLGT) US $0.541B 0.00
Veradigm (MDRX) US $0.531B 0.00
Standard BioTools (LAB) US $0.467B 0.00
Butterfly Network (BFLY) US $0.462B 0.00
Talkspace (TALK) US $0.415B 124.00
TruBridge (TBRG) US $0.336B 746.33
Outset Medical (OM) US $0.309B 0.00
Nyxoah SA (NYXH) BE $0.280B 0.00
Health Catalyst (HCAT) US $0.254B 0.00
SOPHiA GENETICS SA (SOPH) CH $0.248B 0.00
CapsoVision (CV) US $0.211B 0.00
Zepp Health (ZEPP) NL $0.191B 0.00
KORU Medical Systems (KRMD) US $0.155B 0.00
Pulmonx (LUNG) US $0.127B 0.00
American Well (AMWL) US $0.126B 0.00
EUDA Health Holdings (EUDA) SG $0.117B 0.00
MDxHealth SA (MDXH) BE $0.114B 0.00
CareCloud (CCLD) US $0.101B 3.85
Insight Molecular Diagnostics (IMDX) US $0.082B 0.00
ImmunoPrecise Antibodies (IPA) CA $0.079B 0.00
111 (YI) CN $0.066B 0.00
P3 Health Partners (PIII) US $0.048B 0.00
HeartBeam (BEAT) US $0.043B 0.00
Zhongchao (ZCMD) CN $0.028B 0.00
Streamline Health Solutions (STRM) US $0.023B 0.00
Precipio (PRPO) US $0.022B 0.00
Bullfrog AI Holdings (BFRG) US $0.014B 0.00
Strata Skin Sciences (SSKN) US $0.009B 0.00
Healthcare Triangle (HCTI) US $0.008B 0.00
MSP Recovery (MSPR) US $0.008B 0.00
Predictive Oncology (POAI) US $0.007B 0.00
Movano (MOVE) US $0.005B 0.00
HeartSciences (HSCS) US $0.004B 0.00
Evaxion - (EVAX) DK $0.004B 0.00
Tivic Health Systems (TIVC) US $0.004B 0.00
Mobile-health Network Solutions (MNDR) SG $0.003B 0.00
Future Health ESG (FHLT) US $0.000B 0.00